Scarica l'app Stockscreener
2.785
0.54%
-0.015
Autolus Therapeutics Plc Adr Borsa (AUTL) Ultime notizie
These Numbers Prove Just How Vibrant The Ocugen Inc (NASDAQ: OCGN) Stock Has Been - Stocks Register
Autolus stock upgraded as obe-cel approval drives optimism for commercial potential - Investing.com
Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 - Barchart
Does MP Materials Corporation (NYSE: MP) Still Need To Convince Analysts? - Stocks Register
Hafnia Ltd (NYSE: HAFN) Drops -3.00%, Turning Investors Away - Stocks Register
PDD Holdings Inc ADR (NASDAQ: PDD) Has Been Trading Down. What Are The Prospects For The Future? - Stocks Register
What Do Wall Street Analysts Think About Moderna Inc (NASDAQ: MRNA) Stock? - Stocks Register
Before You Invest, Make Sure You Check This Autolus Therapeutics plc ADR (NASDAQ: AUTL) Analysis - Stocks Register
Autolus Therapeutics plc ADR (AUTL)’s stock rises to 4.14 per share - US Post News
Autolus Therapeutics plc ADR: -44.83% Growth from 52-Week Low, Yet Analysts Divided - The InvestChronicle
A better buy-in window may exist right now for Autolus Therapeutics plc ADR (AUTL) - SETE News
Upward Trajectory: Autolus Therapeutics plc ADR (AUTL) Posts a Slidee, Closing at 3.98 - The Dwinnex
Autolus Therapeutics plc ADR (AUTL) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Are Smart Investors Making the Right Decision? Autolus Therapeutics plc ADR (AUTL) - SETE News
Autolus Therapeutics plc ADR (AUTL) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Autolus Therapeutics plc ADR (AUTL)’s stock chart: A technical perspective - US Post News
Stock Performance Spotlight: Autolus Therapeutics plc ADR (AUTL) Ends the Day at 3.63, Up by 4.31 - The Dwinnex
A look into Autolus Therapeutics plc ADR (AUTL)’s deeper side - SETE News
Are Autolus Therapeutics plc ADR (AUTL) shares a good deal now? - US Post News
Autolus Therapeutics plc ADR (AUTL)’s Market Momentum: Closing Strong at 3.73, Down -3.12 - The Dwinnex
Autolus Therapeutics (NASDAQ:AUTL) Shares Down 4.8% - MarketBeat
Autolus Therapeutics names new Chief Development Officer - Investing.com India
Autolus Therapeutics names new Chief Development Officer By Investing.com - Investing.com South Africa
Autolus Therapeutics plc (NASDAQ:AUTL) Short Interest Down 8.0% in August - Defense World
Autolus Therapeutics plc ADR (AUTL) looking to reclaim success with recent performance - SETE News
Autolus Therapeutics plc ADR (AUTL) Stock: Navigating a Year of Volatility - The InvestChronicle
Autolus Therapeutics plc (NASDAQ:AUTL) Shares Acquired by Daiwa Securities Group Inc. - Defense World
Autolus Therapeutics plc ADR (AUTL)’s stock price in review: A technical analysis - US Post News
Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up to $4.08 - MarketBeat
Financial Metrics Check: Autolus Therapeutics plc ADR (AUTL)’s Ratios for Trailing Twelve Months - The Dwinnex
Autolus secures £18.5M for facility upgrades - Investing.com
Autolus Therapeutics plc ADR (AUTL) is looking forward to a strong quarter - SETE News
Trading Day Review: Autolus Therapeutics plc ADR (AUTL) Gains Momentum, Closing at 4.12 - The Dwinnex
Autolus Therapeutics plc ADR (AUTL) presents a great opportunity, but the stock is slightly overvalued - US Post News
Autolus Therapeutics (NASDAQ:AUTL) Stock Price Up 6% - MarketBeat
Autolus Therapeutics (NASDAQ:AUTL) Stock Price Down 3.4% - MarketBeat
It is Poised to be a Bull Market for Autolus Therapeutics plc ADR (AUTL) - SETE News
Contrasting Autolus Therapeutics (NASDAQ:AUTL) & ZIVO Bioscience (NASDAQ:ZIVO) - Defense World
Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today - GlobeNewswire Inc.
Autolus reports promising results for obe-cel in leukemia study - Investing.com India
Views of Wall Street’s Leading Experts on Autolus Therapeutics plc ADR - SETE News
Is Autolus Therapeutics plc ADR (AUTL) a good investment opportunity? - US Post News
SG Americas Securities LLC Purchases 169,387 Shares of Autolus Therapeutics plc (NASDAQ:AUTL) - Defense World
Take off with Autolus Therapeutics plc ADR (AUTL): Get ready for trading - SETE News
Examining Autolus Therapeutics plc ADR (AUTL) stock is warranted - US Post News
Autolus Therapeutics plc ADR (AUTL)’s Market Momentum: Closing Strong at 3.75, Up 1.90 - The Dwinnex
Financial Survey: Autolus Therapeutics (NASDAQ:AUTL) and Cognition Therapeutics (NASDAQ:CGTX) - Defense World
Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up to $3.64 - Defense World
Cetera Advisors LLC Invests $839,000 in Autolus Therapeutics plc (NASDAQ:AUTL) - Defense World
How Analyst Ratings Affect Autolus Therapeutics plc ADR Inc. (AUTL) Price Performance - The InvestChronicle
Understanding the Risks and Rewards of Investing in SES AI Corporation Inc. (SES) Based on Price Performance - The InvestChronicle
Aptiv PLC: Rising -36.09% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
i-80 Gold Corp (IAUX) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Investor’s Delight: Autolus Therapeutics plc ADR (AUTL) Closes Weak at 3.90, Down -8.24 - The Dwinnex
Have you been able to find a good deal on Autolus Therapeutics plc ADR’s shares? - US Post News
Stock Performance Spotlight: Autolus Therapeutics plc ADR (AUTL) Ends the Day at 4.47, Down by -3.46 - The Dwinnex
Investing in Autolus Therapeutics plc ADR (AUTL) might be a great opportunity, but the stock is a bit undervalued - US Post News
Ready to Jump After Recent Trade: Autolus Therapeutics plc ADR (AUTL) - SETE News
Uncovering the Potential of Autolus Therapeutics plc ADR (AUTL) Stock - The InvestChronicle
Autolus Therapeutics plc (NASDAQ:AUTL) Sees Large Growth in Short Interest - Defense World
Results from Autolus Therapeutics plc ADR (AUTL) show potential - US Post News
Autolus Therapeutics plc ADR (AUTL) expanding its growth trajectory ahead - SETE News
Market Watch Highlights: Autolus Therapeutics plc ADR (AUTL) Ends on an Downturn Note at 4.43 - The Dwinnex
Short Interest in Autolus Therapeutics plc (NASDAQ:AUTL) Expands By 5.9% - American Banking and Market News
A stock that deserves closer examination: Autolus Therapeutics plc ADR (AUTL) - US Post News
Short Interest in Autolus Therapeutics plc (NASDAQ:AUTL) Rises By 5.9% - MarketBeat
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):